Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Ocular Therapeutix Inc., 3 years.
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Ocular Therapeutix Inc. June 14, 202380.7%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 2, 2026 | Ocular Therapeutix Inc. | Open-market sale | −10,869 | $7.05 | $76,626 |
| Aug 24, 2026 | Ocular Therapeutix Inc. | Open-market sale | −3,296 | $10.78 | $35,531 |
| May 26, 2026 | Ocular Therapeutix Inc. | Open-market sale | −3,018 | $8.20 | $24,748 |
| Feb 23, 2026 | Ocular Therapeutix Inc. | Open-market sale | −3,057 | $8.28 | $25,312 |
| Jan 2, 2026 | Ocular Therapeutix Inc. | Grant or award | +79,112 | — | — |
| Nov 24, 2025 | Ocular Therapeutix Inc. | Open-market sale | −3,469 | $12.04 | $41,767 |
| Oct 2, 2025 | Ocular Therapeutix Inc. | Open-market sale | −10,502 | $11.04 | $115,942 |
| Aug 25, 2025 | Ocular Therapeutix Inc. | Open-market sale | −3,063 | $12.04 | $36,879 |
| May 23, 2025 | Ocular Therapeutix Inc. | Open-market sale | −3,024 | $7.18 | $21,712 |
| Feb 24, 2025 | Ocular Therapeutix Inc. | Open-market sale | −3,061 | $6.87 | $21,029 |
| Nov 25, 2024 | Ocular Therapeutix Inc. | Open-market sale | −2,948 | $9.01 | $26,561 |
| Oct 2, 2024 | Ocular Therapeutix Inc. | Grant or award | +100,000 | — | — |
| Jun 14, 2023 | Ocular Therapeutix Inc. | Grant or award | +12,000 | — | — |
Questions about Jeffrey S. Heier
What boards is Jeffrey S. Heier on?
Jeffrey S. Heier sits on the board of Ocular Therapeutix Inc.
How long has Jeffrey S. Heier served on boards?
Our records show at least 3 years of board service across 1 board, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.